Relative to routine stenting, drug-eluting balloon revascularization with as-needed stenting produced similarly low target ...
Canada: Researchers have found that a sirolimus-eluting balloon strategy may offer a safe and effective alternative to ...
Sirolimus-eluting stents reduce rates of restenosis and reintervention, as compared with uncoated stents. Data are limited regarding the safety and efficacy of such stents in primary percutaneous ...
The two medications can be administered concomitantly if various factors are taken into account. CHICAGO—Clinicians can safely use sirolimus and voriconazole concurrently if certain steps are followed ...
Please provide your email address to receive an email when new articles are posted on . Four of six patients who used sirolimus had positive responses and discontinued systemic corticosteroids. Three ...
Preliminary reports of studies involving simple coronary lesions indicate that a sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary revascularization. The ...
A sirolimus eluting balloon performs similarly to a usual care strategy for repeat coronary in stent restenosis at 1 year, ...
Acute GVHD (aGVHD) is a major cause of morbidity and mortality in hematopoietic allograft recipients. The best therapy for patients failing to respond, or not tolerating, systemic glucocorticoids ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results